Skip to content

Development of an Intelligent Assessment System for Dynamic Prediction of the Risk of Malignant Transformation in Oral Leukoplakia

Development of an Intelligent Assessment System for Dynamic Prediction of the Risk of Malignant Transformation in Oral Leukoplakia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600127797
Enrollment
Unknown
Registered
2026-07-07
Start date
2026-07-08
Completion date
Unknown
Last updated
2026-07-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Oral leukoplakia

Interventions

OLK malignant transformation group:None
OLK non-malignant group:None

Sponsors

Beijing Stomatological Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Applicants must be over 18 years old at the time of visit, and gender is not limited. 2. Those diagnosed with oral leukoplakia or accompanied by abnormal hyperplasia/canceration through histopathological diagnosis; 3. The medical records and pathological report data are complete. 4. Before the pathological biopsy, photos of the intraoral lesions were taken. 5. The photo quality meets the research requirements: the lesion is clearly visible and the resolution is greater than or equal to 1200×800 pixels.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Incidence of OLK Malignancy Over a 2-Year Period;Recall rate;F1-score;Area under the receiver operating curve (AUC-ROC);Model calibration degree;Clinical net benefit;

Secondary

MeasureTime frame
Accuracy rate, precision rate;

Countries

China

Contacts

Public ContactGuan Xiaobing

Beijing Stomatological Hospital , Capital Medical University

guanxbing2013@qq.com+86 10 57099246

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026